Sudo Biosciences
Sudo Biosciences is a biopharmaceutical company focused on designing and developing precision TYK2 inhibitors for the treatment of multiple sclerosis, psoriasis, and other autoimmune and neurologic conditions. Their pipeline includes brain-penetrant and topical TYK2 inhibitors, aiming to be first-in-class treatments for various diseases.
Buy Funded Startups lists
Funding Round: Series B
Funding Amount: $147M
Date: 13-Feb-2024
Investors: Enavate Sciences, TPG Life Sciences Innovations, The Rise Fund, Sanofi Ventures, Frazier Life Sciences, Surveyor Capital, Monograph Capital, Eventide Asset Management, Velosity Capital, Dementia Discovery Fund, Leaps by Bayer, UPMC Enterprises
Markets: Biotechnology, Pharmaceuticals, Biopharma, Health Care, Life Science, Medical
HQ: Carmel, Indiana, United States
Founded: 2020
Website: https://www.sudobio.com
LinkedIn: https://www.linkedin.com/company/sudo-biosciences
Crunchbase: https://www.crunchbase.com/organization/sudo-biosciences
Leave a Comment
Comments
No comments yet.